Princess Margaret Hospital, Canada
121
16
30
74
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
6.6%
8 terminated/withdrawn out of 121 trials
90.2%
+3.7% vs industry average
5%
6 trials in Phase 3/4
4%
3 of 74 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (121)
HRQL and Symptom Assessment for Patients With DIPG or Recurrent and Re-irradiated Brain Tumours and Their Caregivers
Role: collaborator
Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)
Role: collaborator
Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression
Role: collaborator
Transrectal Tumour Oxygen - US Army
Role: collaborator
Automated Breast Radiation Therapy Using an MR-Guided Process
Role: collaborator
Cervix: Hypoxia, Interstitial Fluid Pressure and GSH Levels
Role: collaborator
5 Fraction Stereotactic Body Radiation Therapy for Oligometastases Regimen, for Extra-Cranial Oligometastases
Role: collaborator
Stereotactic Radiotherapy (SBRT) of Lung Metastasis
Role: collaborator
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Role: collaborator
Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients on DOAC
Role: collaborator
Integrated Molecular Profiling in Advanced Cancers Trial
Role: collaborator
Selection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic Therapies
Role: collaborator
MRI Screening for Brain Metastases Among Patients With Triple Negative or HER2+ Stage II or III Breast Cancer
Role: collaborator
Short-term Impacts of Endocrine Therapy on Cardiovascular and Brain Health Outcomes in Breast Cancer
Role: collaborator
Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma
Role: collaborator
Predicting Radiological Extranodal Extension in Oropharyngeal Carcinoma Patients Using AI
Role: collaborator
Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!)
Role: collaborator
Stereotactic Body Radiotherapy (SBRT) Post Prostatectomy
Role: collaborator
Low-Flow vs. High-Flow Nasal Cannula for Hypoxemic Immunocompromised Patients During Diagnostic Bronchoscopy
Role: collaborator
A SMART Design to Optimize the Delivery of TEMPO for Men With Prostate Cancer and Their Caregivers
Role: collaborator